Skip to main content
    P

    Pulmatrix Inc (PULM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.37
    +0.04 (+3.01%)

    Market Cap: $4.71M

    Last updated: Nov 17, 2026 at 4:24 PM ET

    Pulmatrix Inc (PULM) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Pulmatrix (PULM) has a market cap of $4.71M and an enterprise value of $3.31M. Revenue fell 100.00% over the last 12 months from the 12 months before. It holds $1.40M more cash than debt, 29.67% of its market cap.

    Total Valuation

    Enterprise value is 29.67% below the market cap, as cash exceeds debt.

    Market Cap$4.71M
    Enterprise Value$3.31M
    Latest price (Nov 17, 2026)$1.37

    Key Dates

    The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 24, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and held steady over 2 years.

    Shares Outstanding3.65M
    Shares Change (YoY)0.00%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)0.00%

    Price Statistics

    The stock is down 70.91% over 52 weeks and trades 6.16% below its 50-day average.

    Beta (1Y)0.22
    52-Week Change-70.91%
    1-Month Change-3.52%
    3-Month Change-9.87%
    6-Month Change+8.73%
    5-Year Change-91.95%
    10-Year Change-99.45%
    Total Return (1Y)-70.91%
    Total Return (3Y CAGR)-8.95%
    Total Return (5Y CAGR)-37.61%
    Return vs SPY (1Y)-81.11%
    Max Drawdown (1Y)-74.95%
    Max Drawdown (3Y)-88.12%
    Sharpe Ratio (1Y)-1.22
    Correlation with SPY (1Y)0.03
    50-Day Average$1.46
    200-Day Average$1.63
    52-Week Range$1.06 to $4.94
    RSI (14 Days)47.5
    Average Volume (20 Days)37.19K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.32x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio2.32x
    Quick Ratio2.32x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -323.11% over the last 12 months, against a 5-year average of -84.77%.

    Return on Equity (ROE)-323.11%
    Return on Assets (ROA)-184.05%
    ROE (5Y Average)-84.77%
    ROA (5Y Average)-68.55%

    Scores

    PULM has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Operating Income-$4.47M
    Pretax Income-$4.35M
    Net Income-$4.35M
    Reported EPS (TTM)-$1.10

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 57.20% of the $2.36M in total assets.

    Cash and Equivalents$1.40M
    Total Debt$0
    Net Cash$1.40M
    Net Cash Per Share$0.38
    Working Capital$1.34M
    Shareholder Equity$1.35M
    Book Value Per Share$0.10
    Total Assets$2.36M
    Total Liabilities$1.02M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$3.65M
    FCF Per Share-$1.00

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Stock Splits

    The last split was a 1-for-20 reverse split on Mar 1, 2022.

    Last Split DateMar 1, 2022
    Split TypeReverse split
    Split Ratio1:20

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About PULM

    What is PULM's market cap?

    Pulmatrix has a market cap of $4.71M. Its enterprise value, which adds debt and subtracts cash, is $3.31M.

    How many shares of PULM are outstanding?

    Pulmatrix has 3.65M shares outstanding. The count is up 0.00% from a year earlier.

    Does PULM pay a dividend?

    No. Pulmatrix does not pay a dividend.

    How much debt does PULM have?

    Pulmatrix has $0 of total debt and $1.40M of cash and equivalents, a net cash position of $1.40M.